华尔街顶级分析师改变了对这些顶级公司的看法。有关所有分析师评级变动的完整视图，包括上调、下调和首次评级，请查看我们的 分析师评级页面。
<ul>
<li>Keybanc 分析师 Bradley B. Thomas 将 Purple Innovation Inc (NASDAQ: PRPL) 的评级从超配下调至行业配置。Purple Innovation 股价周二收于 $0.53。查看其他分析师对该股票的看法。</li>
<li>Barrington Research 分析师 Michael Petusky 将 OPKO Health Inc (NASDAQ: OPK) 的评级从跑赢大盘下调至市场表现。OPKO Health 股价周二收于 $1.21。查看其他分析师对该股票的看法。</li>
<li>JP Morgan 分析师 Drew Levine 将 Brown-Forman Corp(NYSE: BF.B) 的评级从中性下调至弱于大盘，并将目标价从 $27 下调至 $23。Brown-Forman 股价周二收于 $27.73。查看其他分析师对该股票的看法。</li>
<li>UBS 分析师 Kaio Prato 将 MercadoLibre Inc (NASDAQ: MELI) 的评级从买入下调至中性，并将目标价从 $2,700 下调至 $2,050。MercadoLibre 股价周二收于 $1,791.99。查看其他分析师对该股票的看法。</li>
<li>William Blair 分析师 Jonathan Ho 将 Rapid7, Inc. (NASDAQ: RPD) 的评级从跑赢大盘下调至市场表现。Rapid7 股价周二收于 $5.82。查看其他分析师对该股票的看法。</li>
</ul>
考虑购买 PRPL 股票吗？以下是分析师的看法：
<img src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png"/>
图片来源于 Shutterstock

PRPL

拉美商业服务

OPKO保健

BF.B

华尔街分析师已下调了几只股票的评级，包括将 Purple Innovation (PRPL) 从 “增持” 下调至 “行业权重”，将 OPKO Health (OPK) 从 “跑赢大盘” 下调至 “市场表现”，将 Brown-Forman (BF.B) 从 “中性” 下调至 “减持”，并将其目标价从 27 美元下调至 23 美元，将 MercadoLibre (MELI) 从 “买入” 下调至 “中性”，目标价从 2,700 美元下调至 2,050 美元，以及将 Rapid7 (RPD) 从 “跑赢大盘” 下调至 “市场表现”。分析师对这些变化提供了见解，反映出市场情绪的转变

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
<div class="lb-trans">华尔街顶级分析师改变了对这些顶级公司的看法。有关所有分析师评级变动的完整视图，包括上调、下调和首次评级，请查看我们的 分析师评级页面。
</div><ul>
<li>Keybanc analyst Bradley B. Thomas downgraded Purple Innovation Inc (NASDAQ: PRPL) from Overweight to Sector Weight. Purple Innovation shares closed at $0.53 on Tuesday. See how other analysts view this stock.</li>
<li>Barrington Research analyst Michael Petusky downgraded OPKO Health Inc (NASDAQ: OPK) from Outperform to Market Perform. OPKO Health shares closed at $1.21 on Tuesday. See how other analysts view this stock.</li>
<li>JP Morgan analyst Drew Levine downgraded Brown-Forman Corp(NYSE: BF.B) from Neutral to Underweight and cut the price target from $27 to $23. Brown-Forman shares closed at $27.73 on Tuesday. See how other analysts view this stock.</li>
<li>UBS analyst Kaio Prato downgraded MercadoLibre Inc (NASDAQ: MELI) from Buy to Neutral and cut the price target from $2,700 to $2,050. MercadoLibre shares closed at $1,791.99 on Tuesday. See how other analysts view this stock.</li>
<li>William Blair analyst Jonathan Ho downgraded Rapid7, Inc. (NASDAQ: RPD) from Outperform to Market Perform. Rapid7 shares closed at $5.82 on Tuesday. See how other analysts view this stock.</li>
</ul>
<div class="lb-trans"><ul>
<li>Keybanc 分析师 Bradley B. Thomas 将 Purple Innovation Inc (NASDAQ: PRPL) 的评级从超配下调至行业配置。Purple Innovation 股价周二收于 $0.53。查看其他分析师对该股票的看法。</li>
<li>Barrington Research 分析师 Michael Petusky 将 OPKO Health Inc (NASDAQ: OPK) 的评级从跑赢大盘下调至市场表现。OPKO Health 股价周二收于 $1.21。查看其他分析师对该股票的看法。</li>
<li>JP Morgan 分析师 Drew Levine 将 Brown-Forman Corp(NYSE: BF.B) 的评级从中性下调至弱于大盘，并将目标价从 $27 下调至 $23。Brown-Forman 股价周二收于 $27.73。查看其他分析师对该股票的看法。</li>
<li>UBS 分析师 Kaio Prato 将 MercadoLibre Inc (NASDAQ: MELI) 的评级从买入下调至中性，并将目标价从 $2,700 下调至 $2,050。MercadoLibre 股价周二收于 $1,791.99。查看其他分析师对该股票的看法。</li>
<li>William Blair 分析师 Jonathan Ho 将 Rapid7, Inc. (NASDAQ: RPD) 的评级从跑赢大盘下调至市场表现。Rapid7 股价周二收于 $5.82。查看其他分析师对该股票的看法。</li>
</ul>
</div>Considering buying PRPL stock? Here’s what analysts think:
<div class="lb-trans">考虑购买 PRPL 股票吗？以下是分析师的看法：
</div><img src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png" alt="" original-src="https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/29084227/image-685-1024x470.png"/>
Photo via Shutterstock
<div class="lb-trans">图片来源于 Shutterstock
</div>

这位 Purple Innovation 的分析师不再持乐观态度；以下是周三的五大评级下调